Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts-Reference-Cited by-同舟云学术

Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts

Published:2015-05 Issue: Volume:205 Page:144-154
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Zhong Yinan,Zhang Jian,Cheng Ru,Deng Chao,Meng Fenghua,Xie Fang,Zhong Zhiyuan

Funder

National Natural Science Foundation of China

National Science Fund for Distinguished Young Scholars

riority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions, and Innovative Graduate Research Program of Jiangsu Province

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Cancer drug resistance: an evolving paradigm;Holohan;Nat. Rev. Cancer,2013

2. Multiple molecular mechanisms for multidrug resistance transporters;Higgins;Nature,2007

3. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat. Nanotechnol.,2007

4. Nanoparticle therapeutics: an emerging treatment modality for cancer;Davis;Nat. Rev. Drug Discov.,2008

5. Self-assembled polymer nanostructures for delivery of anticancer therapeutics;Wiradharma;Nano Today,2009

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in drugs restructured with nanomedicines for multiple myeloma treatment;Science China Materials;2024-09-10

2. Self-enhanced targeted nanomedicines based on iron starvation acclimation for tumor-specific therapy;Chemical Engineering Journal;2024-09

3. Biomolecule‐responsive polymers and their bio‐applications;Interdisciplinary Materials;2024-08-14

4. ROS-responsive core–shell nano-inhibitor impedes pyruvate metabolism for reinforced photodynamic therapy and interrupted pre-metastatic niche formation;Acta Biomaterialia;2024-07

5. Hyaluronic Acid Nanoparticles with Parameters Required for In Vivo Applications: From Synthesis to Parametrization;Biomacromolecules;2024-06-29